EGFR Mutation Targeting Molecular Probe for PET Imaging

Not yet recruitingOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

November 15, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Cancer
Interventions
DRUG

18F-LF13

18F-LF13 PET/CT: after intravenous injection of 1.85 - 3.7 MBq/kg body weight of quality-controlled 18F-LF13, a Siemens Biograph PET/CT scan will be applied within 0.5 h, and the scan range will be from the top of the head to 1/3 of the upper thigh, 2 h to 4 h delayed scanning can be added if necessary.

Trial Locations (1)

100142

Beijing Cancer Hospital, Beijing

All Listed Sponsors
lead

Peking University Cancer Hospital & Institute

OTHER

NCT06641674 - EGFR Mutation Targeting Molecular Probe for PET Imaging | Biotech Hunter | Biotech Hunter